Tmc Life Sciences Berhad operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tmc Life Sciences Berhad with three other
health care providers in Asia:
Ceylon Hospitals PLC
of Sri Lanka
sales of 5.73 billion Sri Lanka Rupees [US$32.57 million]
(3.82 billion Indian Rupees [US$52.65 million]
Nawaloka Hospitals PLC
based in Sri Lanka
(7.96 billion Sri Lanka Rupees [US$45.19 million]
Tmc Life Sciences Berhad reported sales of 169.04 million Malaysian Ringgits (US$40.31 million)
August of 2018.
increase of 11.4%
versus 2017, when the company's sales were 151.71 million Malaysian Ringgits.
Sales at Tmc Life Sciences Berhad have increased during each of the previous five years
(and since 2013, sales have increased a total of 134%).